7. Epi Campus 2025: Comprehensive Dees Patient Care
- BIELEFELD, Germany – A extensive training event, Epi Campus, will address the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs) on June 27 and 28, 2025, in...
- The core of DEE patient care involves early and accurate diagnosis of both the epilepsy syndrome and its underlying cause.
- Organizers emphasize the importance of the patient's perspective.
Epi Campus 2025: Focus on Developmental and Epileptic Encephalopathies
BIELEFELD, Germany – A extensive training event, Epi Campus, will address the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs) on June 27 and 28, 2025, in Bielefeld. The event is under the scientific direction of Prof. Dr. Christian Brandt of University Hospital Bielefeld.
Comprehensive Treatment Strategies for DEEs
The core of DEE patient care involves early and accurate diagnosis of both the epilepsy syndrome and its underlying cause. Rapid implementation of the most effective therapies, alongside management of symptoms beyond seizure control, are also critical components.
The Patient Viewpoint: A central Focus
Organizers emphasize the importance of the patient’s perspective. Understanding the experiences and needs of patients and thier families is paramount to providing comprehensive, patient-centered care. A deep understanding of these perspectives is essential for optimizing treatment approaches.
Expert Speakers and collaborative Discussions
The program features lectures from national and international experts. Joint discussions are intended to foster valuable insights and new perspectives to further improve DEE treatment strategies.
Continuing Medical Education (CME) Chance
Free CME training will be available on-site in Bielefeld and virtually.
Event Details
Dates: Friday, June 27, 2025, 4:00 p.m. - 7:30 p.m. and Saturday, June 28, 2025, 9:00 a.m. – 3:30 p.m.
Featured Speakers
- Prof. Dr. Christian Brandt, Bielefeld (Scientific Director)
- Zulfiya Mirzadjanova, Bielefeld
- Dr. Volker Sepeur
- Prof. Dr. Heidrun Potschka, Munich
- Prof. Stéphane Auvin, Paris
- Dr. Pia Zacher,Ahrweiler
- Prof. Dr. Christoph Helmstädter, Bonn
- Dr. Tilman Polster, Bielefeld
- Prof. Jacqueline A. French, New York
- Prof. Dr. Dr. Stephen Kovaç, Münster
- Prof. dr. Rainer Surges, Bonn
- Dr. Frank Bösebeck, Rotenburg
- Dr. Berthold Voges, Hamburg
- Dr. Hannah Perst, Braunschweig
Provider of further training: Jazz Pharmaceuticals
Organizer Website: Jazz Pharmaceuticals
Contact: kontakt@epi-campus-2025.de
About Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC (Nasdaq: Jazz) is a global biopharmaceutical company focused on improving the lives of patients and their families through innovative medicines. The company is committed to developing treatments for serious illnesses where therapeutic options are limited or non-existent. Jazz Pharmaceuticals has a broad portfolio of marketed medications and product candidates in neuroscience and oncology, spanning early- to late-stage development. The company researches biologically and chemically produced active ingredients, innovative management technologies, and cannabinoids to discover new therapy options. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals employs patient-focused individuals in approximately 75 countries.
Here’s a Q&A-style blog post based on the provided information, designed to be informative, engaging, and SEO-friendly.
Epi Campus 2025: Your Questions Answered About DEEs
What is Epi Campus 2025?
Epi Campus 2025 is a training event dedicated to the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs). It’s designed to provide healthcare professionals with the latest information and strategies for managing these challenging conditions.The event will be held in Bielefeld, Germany, on June 27 and 28, 2025.
who is organizing this event?
The event is provided by Jazz Pharmaceuticals, a global biopharmaceutical company.
Who is the scientific director of Epi Campus 2025?
The scientific direction is under the guidance of Prof.Dr. Christian Brandt of University Hospital Bielefeld.
What are Developmental and Epileptic Encephalopathies (DEEs)?
DEEs are a group of severe neurological disorders characterized by both developmental delays and epileptic seizures. These conditions can significantly impact a patient’s quality of life, making thorough treatment essential.
What will be covered at the training event?
The core focus of the training will be on comprehensive treatment strategies for DEEs. This includes:
Early and Accurate Diagnosis: Identifying both the epilepsy syndrome and its underlying cause.
Effective Therapies: Rapid implementation of the most appropriate treatments.
Symptom Management: Addressing symptoms beyond seizure control.
Patient-Centered Care: The event will emphasize the importance of the patient’s outlook and understanding the needs of patients and their families.
Why is the patient’s perspective so crucial?
Understanding the experiences and needs of patients and their families is considered paramount to providing comprehensive, patient-centered care. Focusing on the patient’s viewpoint is essential for optimizing treatment approaches and improving outcomes.
Will there be expert speakers?
Yes! the program features lectures from national and international experts in the field of DEEs. There will also be collaborative discussions to encourage valuable insights and new perspectives to further improve DEE treatment strategies.
Will CME credits be available?
Yes, free Continuing Medical education (CME) training will be available both on-site in Bielefeld and virtually.
What are the event details?
Dates: Friday, June 27, 2025, from 4:00 p.m. to 7:30 p.m. and Saturday,June 28,2025,from 9:00 a.m. to 3:30 p.m.
Location: Bielefeld, Germany.
Who are some of the featured speakers?
The event boasts an impressive roster of experts, including:
Prof. Dr. Christian Brandt (Scientific Director, Bielefeld)
Zulfiya Mirzadjanova, Bielefeld
Dr. Volker Sepeur
prof. Dr.Heidrun Potschka, Munich
Prof. Stéphane auvin, Paris
dr. pia zacher, Ahrweiler
Prof.Dr. Christoph Helmstädter, bonn
dr. Tilman polster, Bielefeld
Prof.Jacqueline A. French, New York
Prof. dr. Dr. Stephen Kovaç, Münster
Prof.dr. Rainer Surges, Bonn
Dr. Frank Bösebeck, Rotenburg
Dr. Berthold Voges, Hamburg
Dr. Hannah Perst, Braunschweig
How can I learn more about the event or contact the organizers?
You can find more information on the jazz Pharmaceuticals website: Jazz Pharmaceuticals.
For specific inquiries, you can contact the organizers at: kontakt@epi-campus-2025.de.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals PLC (Nasdaq: Jazz) is a global biopharmaceutical company committed to improving the lives of patients through innovative medicines.The company focuses on developing treatments for serious illnesses where therapeutic options are limited. They have a diverse portfolio of marketed medications and product candidates in neuroscience and oncology. Jazz Pharmaceuticals researches biologically and chemically produced active ingredients, innovative management technologies, and cannabinoids to discover new therapy options. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals employs patient-focused individuals in approximately 75 countries.
